{"title":"利用临床和实验室数据通过机器学习模型预测妊娠早期子痫前期。","authors":"Songchang Chen, Jia Li, Xiao Zhang, Wenqiu Xu, Zhixu Qiu, Siyao Yan, Wenrui Zhao, Zhiguang Zhao, Peirun Tian, Qiang Zhao, Qun Zhang, Weiping Chen, Huahua Li, Xiaohong Ruan, Gefei Xiao, Sufen Zhang, Liqing Hu, Jie Qin, Wuyan Huang, Zhongzhe Li, Shunyao Wang, Rui Zhang, Shang Huang, Xin Wang, Yao Yao, Jian Ran, Danling Cheng, Qi Luo, Teng Pan, Ruyun Gao, Jing Zheng, Yuxuan Wang, Cong Liu, Xianling Cao, Xuanyou Zhou, Naixin Xu, Lanlan Zhang, Xu Han, Haolin Wang, Suihua Feng, Shuyuan Li, Jianguo Zhang, Lijian Zhao, Fengxiang Wei","doi":"10.1186/s12911-025-02999-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study was performed to characterize the relationship of various laboratory test indicators with clinical information and Preeclampsia (PE) development. Then, prediction models for early-onset preeclampsia (EOPE), late-onset preeclampsia (LOPE), and preterm preeclampsia (Preterm PE) were developed using maternal characteristics and laboratory data.</p><p><strong>Methods: </strong>Between January 2019 and December 2021, we retrospectively recruited 144 EOPE, 363 LOPE, 231 Preterm PE, and 1458 healthy participants from six hospitals. We utilized all available clinical and laboratory data obtained during routine prenatal visits in early pregnancy. The models for EOPE, LOPE, and Preterm PE were created using ensemble machine learning models with patient clinical and laboratory data.</p><p><strong>Results: </strong>By comparing laboratory variables between PE patients and healthy controls, we identified 7, 18, 8, 15, 7,29 laboratory markers for EOPE, LOPE, and Preterm PE, severe PE, superimposed PE, first-time PE respectively. The ensemble EOPE and LOPE models incorporating clinical and laboratory predictors outperformed the clinical factor models respectively. The ensemble EOPE model demonstrated good sensitivity (72.22%,95% confidence interval [CI]: 57.59%-86.85%) and specificity (85.25%,95% CI: 80.54%-89.97%) in distinguishing EOPE from controls in early pregnancy. Similarly, the ensemble LOPE model showed good accuracy in differentiating LOPE from healthy participants (sensitivity: 69.57%, 95% CI: 56.27%-82.86%; specificity: 85.25%, 95% CI: 80.54%-89.97%). The prediction scores demonstrated notable positive correlations with blood pressure at admission, while they showed inverse correlations with 24-hour urine protein levels and fetal growth restriction among PE patients. In conclusion, our study identified key laboratory indicators for forecasting PE. The developed models exhibited good predictive capability for assessing preeclampsia risk and severity based on clinical and laboratory data.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9340,"journal":{"name":"BMC Medical Informatics and Decision Making","volume":"25 1","pages":"178"},"PeriodicalIF":3.3000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12044989/pdf/","citationCount":"0","resultStr":"{\"title\":\"Predicting preeclampsia in early pregnancy using clinical and laboratory data via machine learning model.\",\"authors\":\"Songchang Chen, Jia Li, Xiao Zhang, Wenqiu Xu, Zhixu Qiu, Siyao Yan, Wenrui Zhao, Zhiguang Zhao, Peirun Tian, Qiang Zhao, Qun Zhang, Weiping Chen, Huahua Li, Xiaohong Ruan, Gefei Xiao, Sufen Zhang, Liqing Hu, Jie Qin, Wuyan Huang, Zhongzhe Li, Shunyao Wang, Rui Zhang, Shang Huang, Xin Wang, Yao Yao, Jian Ran, Danling Cheng, Qi Luo, Teng Pan, Ruyun Gao, Jing Zheng, Yuxuan Wang, Cong Liu, Xianling Cao, Xuanyou Zhou, Naixin Xu, Lanlan Zhang, Xu Han, Haolin Wang, Suihua Feng, Shuyuan Li, Jianguo Zhang, Lijian Zhao, Fengxiang Wei\",\"doi\":\"10.1186/s12911-025-02999-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>This study was performed to characterize the relationship of various laboratory test indicators with clinical information and Preeclampsia (PE) development. Then, prediction models for early-onset preeclampsia (EOPE), late-onset preeclampsia (LOPE), and preterm preeclampsia (Preterm PE) were developed using maternal characteristics and laboratory data.</p><p><strong>Methods: </strong>Between January 2019 and December 2021, we retrospectively recruited 144 EOPE, 363 LOPE, 231 Preterm PE, and 1458 healthy participants from six hospitals. We utilized all available clinical and laboratory data obtained during routine prenatal visits in early pregnancy. The models for EOPE, LOPE, and Preterm PE were created using ensemble machine learning models with patient clinical and laboratory data.</p><p><strong>Results: </strong>By comparing laboratory variables between PE patients and healthy controls, we identified 7, 18, 8, 15, 7,29 laboratory markers for EOPE, LOPE, and Preterm PE, severe PE, superimposed PE, first-time PE respectively. The ensemble EOPE and LOPE models incorporating clinical and laboratory predictors outperformed the clinical factor models respectively. The ensemble EOPE model demonstrated good sensitivity (72.22%,95% confidence interval [CI]: 57.59%-86.85%) and specificity (85.25%,95% CI: 80.54%-89.97%) in distinguishing EOPE from controls in early pregnancy. Similarly, the ensemble LOPE model showed good accuracy in differentiating LOPE from healthy participants (sensitivity: 69.57%, 95% CI: 56.27%-82.86%; specificity: 85.25%, 95% CI: 80.54%-89.97%). The prediction scores demonstrated notable positive correlations with blood pressure at admission, while they showed inverse correlations with 24-hour urine protein levels and fetal growth restriction among PE patients. In conclusion, our study identified key laboratory indicators for forecasting PE. The developed models exhibited good predictive capability for assessing preeclampsia risk and severity based on clinical and laboratory data.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>\",\"PeriodicalId\":9340,\"journal\":{\"name\":\"BMC Medical Informatics and Decision Making\",\"volume\":\"25 1\",\"pages\":\"178\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12044989/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Medical Informatics and Decision Making\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12911-025-02999-5\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICAL INFORMATICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medical Informatics and Decision Making","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12911-025-02999-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL INFORMATICS","Score":null,"Total":0}
Predicting preeclampsia in early pregnancy using clinical and laboratory data via machine learning model.
Background: This study was performed to characterize the relationship of various laboratory test indicators with clinical information and Preeclampsia (PE) development. Then, prediction models for early-onset preeclampsia (EOPE), late-onset preeclampsia (LOPE), and preterm preeclampsia (Preterm PE) were developed using maternal characteristics and laboratory data.
Methods: Between January 2019 and December 2021, we retrospectively recruited 144 EOPE, 363 LOPE, 231 Preterm PE, and 1458 healthy participants from six hospitals. We utilized all available clinical and laboratory data obtained during routine prenatal visits in early pregnancy. The models for EOPE, LOPE, and Preterm PE were created using ensemble machine learning models with patient clinical and laboratory data.
Results: By comparing laboratory variables between PE patients and healthy controls, we identified 7, 18, 8, 15, 7,29 laboratory markers for EOPE, LOPE, and Preterm PE, severe PE, superimposed PE, first-time PE respectively. The ensemble EOPE and LOPE models incorporating clinical and laboratory predictors outperformed the clinical factor models respectively. The ensemble EOPE model demonstrated good sensitivity (72.22%,95% confidence interval [CI]: 57.59%-86.85%) and specificity (85.25%,95% CI: 80.54%-89.97%) in distinguishing EOPE from controls in early pregnancy. Similarly, the ensemble LOPE model showed good accuracy in differentiating LOPE from healthy participants (sensitivity: 69.57%, 95% CI: 56.27%-82.86%; specificity: 85.25%, 95% CI: 80.54%-89.97%). The prediction scores demonstrated notable positive correlations with blood pressure at admission, while they showed inverse correlations with 24-hour urine protein levels and fetal growth restriction among PE patients. In conclusion, our study identified key laboratory indicators for forecasting PE. The developed models exhibited good predictive capability for assessing preeclampsia risk and severity based on clinical and laboratory data.
期刊介绍：
BMC Medical Informatics and Decision Making is an open access journal publishing original peer-reviewed research articles in relation to the design, development, implementation, use, and evaluation of health information technologies and decision-making for human health.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
